Our Fight

Redefining care for people with non-healing tissues.

Acute and chronic impaired healing often lead to debilitating conditions that prevent people of all ages from living an engaged, fulfilling life. At Avobis, we fight every day to help patients reclaim the quality of life they love by developing durable tissue healing solutions.

Our Technology

Durable tissue healing – by your own body.

We are driven to help patients with non-healing tissues get their lives back on track – rather than simply managing their symptoms.

Our focus is creating a transformative implantable tissue healing technology. Derived from the combination of MSCs and bioabsorbable materials, it amplifies the body’s natural ability to heal. We aim to deliver more effective and lasting results while reducing the risk of complications.

Pioneering clinical advancement

Tackling Crohn’s perianal fistula

Avobis is working diligently to bring new hope for patients grappling with chronic fistulas related to Crohn’s Disease. Our lead product, AVB-114, is being investigated to assess healing and outcomes for patients with perianal fistula. By targeting the complex nature of this notoriously difficult-to-treat condition, we’re aiming to open doors to more effective therapeutic options in a field where progress has been historically difficult.

Our culture

Ingenuity is in our DNA.

Led by a seasoned team with a successful clinical and business track record, we are, at our core, a group of innovators. Fueled by creativity and a forward-thinking approach, our diverse pool of talented experts work together tirelessly to deliver inventive solutions to complex problems and help patients’ bodies heal themselves.

years in business
0
Patients in clinical trials
0
identified indications
0

Tiffany J. Brown, PhD

Chief Executive Officer

Tiffany leads Avobis Bio as Chief Executive Officer, Chief Compliance Officer and Board Member. She has been passionate about regenerative medicine for 25 years and focused her career on ensuring patients have access to therapies to transform their lives. In her early career, Tiffany developed new products from clinical concept through technology development, global regulatory approvals and commercial sales. She went on to lead a multi-million dollar global portfolio of therapeutics for general surgical, bariatric and colorectal conditions with assets from pre-clinical stage to market leaders. Tiffany was instrumental in the formation of Avobis Bio, bringing together capabilities of Gore and Mayo Clinic, establishing the team and accelerating operational execution. She holds a PhD in Biomedical Engineering from Georgia Tech and Emory University. Tiffany enjoys immersion in global cultures, opportunities to travel and staying active with her husband and children.